UK markets open in 3 hours 13 minutes

Applied UV, Inc. (AUVI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.7154-0.0246 (-3.32%)
At close: 04:00PM EDT
0.6878 -0.03 (-3.86%)
After hours: 07:39PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.7400
Open0.7000
Bid0.6767 x 400
Ask0.7500 x 600
Day's range0.6700 - 0.7155
52-week range0.6700 - 92.5000
Volume325,237
Avg. volume342,741
Market cap2.583M
Beta (5Y monthly)N/A
PE ratio (TTM)0.00
EPS (TTM)182.5000
Earnings date20 May 2024 - 24 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Applied UV, Inc. Announces Closing of $2.76 Million Registered Direct and Private Placement

    NEW YORK, NY, April 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (NASDAQ: AUVI) (the “Company”), a leader in smart building technology solutions, today announced the closing of its previously announced registered direct offering and concurrent private placement with institutional investors. The Company issued shares of common stock of the Company (“Common Stock”) and pre-funded warrants (“Pre-Funded Warrants”) in a registered direct offering. In a concurrent private placemen

  • GlobeNewswire

    Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules

    NEW YORK, NY, March 27, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (NASDAQ: AUVI; AUVIP) (“Applied UV” or the “Company”), a leader in smart building technology solutions, today announced that it has entered into definitive agreements with institutional investors for the purchase and sale of common stock of the Company (“Common Stock”) and pre-funded warrants (“Pre-Funded Warrants”) in a registered direct offering. In a concurrent private placement, the Company also agreed to s

  • GlobeNewswire

    Applied UV’s Subsidiary Files Patent Application for New Industry Disruptive Integrated Disinfection System for Healthcare Facilities

    Applied UV, Inc. PURONet, Surgical Level of Disinfection Aligns with Company’s strategic focus on bringing to market state-of-the-art advanced disinfection systems NEW YORK, NY, March 11, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Applied UV, Inc. (“Applied UV” or the “Company”) (Nasdaq: AUVI), a leader in smart building technology solutions, today announced that its SteriLumen subsidiary has filed a new patent application with the United States Patent and Trademark Office (“USPTO”) entitled "